Literature DB >> 2652258

Rapid diagnosis of tuberculosis: laboratory techniques applicable in developing countries.

T M Daniel1.   

Abstract

New technologies for the rapid diagnosis of tuberculosis that can be applied in developing countries where the prevalence of tuberculosis is high are based on methods that permit recognition of either mycobacterial products in clinical specimens or specific host responses to mycobacteria. Mycobacterial antigens can be identified by immunoassays based on the enzyme-linked immunosorbent assay (ELISA). Mycobacterial DNA or rRNA can be identified with the use of single-stranded DNA probes. Both techniques are potentially suitable for use in developing countries, although there remain technical problems associated with the use of sputum samples. Serodiagnosis by ELISA is a promising technique based on recognition of the IgG antibody response of the host. The technique is ready for early application and can be used in developing countries. However, high specificity depends on the use of antigens that are not now generally available. The predictive accuracy of any newly proposed diagnostic technique must be compared with that of direct microscopic examination of sputum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2652258     DOI: 10.1093/clinids/11.supplement_2.s471

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  16 in total

1.  Field evaluation of rapid tests for tuberculosis diagnosis.

Authors:  V Rasolofo; S Chanteau
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  The use of light-emitting diode fluorescence to diagnose mycobacterial lymphadenitis in fine-needle aspirates from children.

Authors:  A C van Wyk; B J Marais; R M Warren; S S van Wyk; C A Wright
Journal:  Int J Tuberc Lung Dis       Date:  2011-01       Impact factor: 2.373

Review 3.  A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis.

Authors:  Karen R Steingart; Megan Henry; Suman Laal; Philip C Hopewell; Andrew Ramsay; Dick Menzies; Jane Cunningham; Karin Weldingh; Madhukar Pai
Journal:  Thorax       Date:  2007-08-03       Impact factor: 9.139

4.  Immunoblot analysis for serodiagnosis of tuberculosis using a 45/47-kilodalton antigen complex of Mycobacterium tuberculosis.

Authors:  S Diagbouga; F Fumoux; A Zoubga; P T Sanou; G Marchal
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

5.  Serodiagnostic efficiency of phospholipid associated protein of Mycobacterium tuberculosis H37Rv.

Authors:  N K Kaushik; P Sharma; A Shah; T A Venkitasubramanian
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402

Review 6.  A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis.

Authors:  Karen R Steingart; Megan Henry; Suman Laal; Philip C Hopewell; Andrew Ramsay; Dick Menzies; Jane Cunningham; Karin Weldingh; Madhukar Pai
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

7.  The impact of HIV on the usefulness of sputum smears for the diagnosis of tuberculosis.

Authors:  R Long; M Scalcini; J Manfreda; M Jean-Baptiste; E Hershfield
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

8.  Detection of Mycobacterium tuberculosis DNA in clinical samples by using a simple lysis method and polymerase chain reaction.

Authors:  L Folgueira; R Delgado; E Palenque; A R Noriega
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

Review 9.  HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment.

Authors:  M C Raviglione; J P Narain; A Kochi
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

10.  Comparison of the modified fluorescent method and conventional Ziehl-Neelsen method in the detection of acidfast bacilli in lymphnode aspirates.

Authors:  Vamseedhar Annam; Mohan H Kulkarni; Rekha B Puranik
Journal:  Cytojournal       Date:  2009-07-18       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.